1. Home
  2. DLO vs GRFS Comparison

DLO vs GRFS Comparison

Compare DLO & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DLO

DLocal Limited

HOLD

Current Price

$14.21

Market Cap

4.5B

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$7.32

Market Cap

5.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLO
GRFS
Founded
2013
1940
Country
Uruguay
Spain
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
5.0B
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
DLO
GRFS
Price
$14.21
$7.32
Analyst Decision
Strong Buy
Hold
Analyst Count
8
2
Target Price
$17.25
$10.15
AVG Volume (30 Days)
1.8M
354.2K
Earning Date
05-14-2026
07-28-2022
Dividend Yield
1.45%
1.80%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$41.00
$4.49
Revenue Next Year
$26.98
$6.42
P/E Ratio
$22.27
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$10.64
$6.96
52 Week High
$16.78
$10.23

Technical Indicators

Market Signals
Indicator
DLO
GRFS
Relative Strength Index (RSI) 42.17 35.57
Support Level $13.28 $7.33
Resistance Level $14.67 $8.41
Average True Range (ATR) 0.43 0.12
MACD -0.13 -0.05
Stochastic Oscillator 2.76 5.76

Price Performance

Historical Comparison
DLO
GRFS

About DLO DLocal Limited

DLocal Ltd is focused on making the complex simple, redefining the online payment experience in emerging markets. Through its technology platform, One dLocal, the company enables world-wide enterprise merchants to get paid (pay-in) and to make payments (pay-out) online in a safe and efficient manner. The company earns revenue from fees charged to merchants in connection with payment processing services for cross-border and local payment transactions. The company operates in a single operating segment, which is payment processing. The company's geographical segments include Latin America and Non-Latin America, with a majority of its revenue being generated from Brazil in the Latin America region.

About GRFS Grifols S.A.

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Share on Social Networks: